IRIS Accounts Production v23.3.1.45 SC688204 director 1.3.22 28.2.23 28.2.23 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC6882042022-02-28SC6882042023-02-28SC6882042022-03-012023-02-28SC6882042021-02-04SC6882042021-02-052022-02-28SC6882042022-02-28SC688204ns10:Originalns15:Scotland2022-03-012023-02-28SC688204ns14:PoundSterlingns10:Original2022-03-012023-02-28SC688204ns10:Originalns10:Director12022-03-012023-02-28SC688204ns10:Original2022-03-012023-02-28SC688204ns10:Original2023-02-28SC688204ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-28SC688204ns10:Originalns10:SmallEntities2022-03-012023-02-28SC688204ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-28SC688204ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-28SC688204ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-28SC688204ns10:Originalns10:FullAccounts2022-03-012023-02-28SC688204ns10:Original2021-02-052022-02-28SC688204ns10:Original12022-03-012023-02-28SC688204ns10:Originalns10:RegisteredOffice2022-03-012023-02-28SC688204ns10:Original2022-02-28SC688204ns10:Originalns5:CurrentFinancialInstruments2023-02-28SC688204ns10:Originalns5:CurrentFinancialInstruments2022-02-28SC688204ns5:ShareCapitalns10:Original2023-02-28SC688204ns5:ShareCapitalns10:Original2022-02-28SC688204ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-28SC688204ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-28SC688204ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-03-012023-02-28SC688204ns10:Originalns5:ComputerEquipment2022-03-012023-02-28SC688204ns10:Originalns5:NetGoodwill2022-02-28SC688204ns10:Originalns5:NetGoodwill2022-03-012023-02-28SC688204ns10:Originalns5:NetGoodwill2023-02-28SC688204ns10:Originalns5:NetGoodwill2022-02-28SC688204ns10:Originalns5:ComputerEquipment2022-02-28SC688204ns10:Originalns5:ComputerEquipment2023-02-28SC688204ns10:Originalns5:ComputerEquipment2022-02-28SC688204ns10:Originalns5:CostValuation2022-02-28SC688204ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-28SC688204ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-02-28SC688204ns10:Original1ns10:Director12022-02-28SC688204ns10:Original1ns10:Director12021-02-04SC688204ns10:Original1ns10:Director12022-03-012023-02-28SC688204ns10:Original1ns10:Director12021-02-052022-02-28SC688204ns10:Original1ns10:Director12023-02-28SC688204ns10:Original1ns10:Director12022-02-28
REGISTERED NUMBER: SC688204 (Scotland)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2023

FOR

BB MEDICAL LIMITED

BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


BB MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2023







DIRECTOR: Lee Riddell





REGISTERED OFFICE: 4d Auchingramont Road
Hamilton
ML3 6JT





REGISTERED NUMBER: SC688204 (Scotland)





ACCOUNTANTS: William Duncan (UK) Limited
Chartered Accountants
4d Auchingramont Road
Hamilton
ML3 6JT

BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

STATEMENT OF FINANCIAL POSITION
28 FEBRUARY 2023

28.2.23 28.2.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 9,600 10,800
Tangible assets 5 2,606 3,327
Investments 6 3,000 3,000
15,206 17,127

CURRENT ASSETS
Debtors 7 23,764 10,000
Cash at bank 39,835 54,371
63,599 64,371
CREDITORS
Amounts falling due within one year 8 24,251 60,060
NET CURRENT ASSETS 39,348 4,311
TOTAL ASSETS LESS CURRENT
LIABILITIES

54,554

21,438

PROVISIONS FOR LIABILITIES 495 632
NET ASSETS 54,059 20,806

CAPITAL AND RESERVES
Called up share capital 102 102
Retained earnings 53,957 20,704
54,059 20,806

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

STATEMENT OF FINANCIAL POSITION - continued
28 FEBRUARY 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 September 2023 and were signed by:





Lee Riddell - Director


BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023


1. STATUTORY INFORMATION

Bb Medical Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Rendering of services
Turnover from the rendering of services, namely the provision of medical services, is recognised by reference to the stage of completion of the service at the statement of financial position date.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Computer equipment - 25% on cost

Impairment of assets
At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in the income statement.

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of impairment loss is recognised immediately in the income statement.

BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


2. ACCOUNTING POLICIES - continued

Financial instruments
Basic financial instruments are recognised as follows:

(i) Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method less any impairment.

(ii) Cash and cash equivalents
Cash and cash equivalents include cash at bank and in hand.

Cash and cash equivalents are shown net of bank overdrafts, which are included as current borrowings in liabilities on the statement of financial position.

(iii) Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - NIL ) .

BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 March 2022
and 28 February 2023 12,000
AMORTISATION
At 1 March 2022 1,200
Amortisation for year 1,200
At 28 February 2023 2,400
NET BOOK VALUE
At 28 February 2023 9,600
At 28 February 2022 10,800

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 March 2022 4,436
Additions 518
At 28 February 2023 4,954
DEPRECIATION
At 1 March 2022 1,109
Charge for year 1,239
At 28 February 2023 2,348
NET BOOK VALUE
At 28 February 2023 2,606
At 28 February 2022 3,327

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 March 2022
and 28 February 2023 3,000
NET BOOK VALUE
At 28 February 2023 3,000
At 28 February 2022 3,000

BB MEDICAL LIMITED (REGISTERED NUMBER: SC688204)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.23 28.2.22
£    £   
Other debtors - 10,000
Director's loan 23,764 -
23,764 10,000

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.23 28.2.22
£    £   
Corporation tax 22,618 22,059
PAYE and NIC 79 -
Director's loan - 36,801
Accrued charges 1,554 1,200
24,251 60,060

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 28 February 2023 and the period ended 28 February 2022:

28.2.23 28.2.22
£    £   
Lee Riddell
Balance outstanding at start of year (36,801 ) -
Amounts advanced 60,565 -
Amounts repaid - (36,801 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 23,764 (36,801 )

The above balance which is due from the director is interest free and has no fixed repayment terms.